Skip to main content
. 2019 Oct 23;87(4):785–795. doi: 10.1038/s41390-019-0623-1

Table 1.

Demographic and clinical features of the global study subjects with severe and mild bronchiolitis

Variable Patients, No. (%)a (N = 682) OR (95% CI) p Value
Severe disease (N = 308) Mild disease (N = 374)
Age, mean (IQR), months 7.9 (0.2–9) 10.3 (3–16) <0.001*
Male sex 180 (58.4) 216 (57.8) 1.0 (0.76–1.39) 0.88
Gestational age, mean (IQR), weeks 38.6 (38–39) 38.7 (38–39) 0.19
Birth weight, mean (SD), g 3367.8 (489.2) 3355.1 (474.4) 0.71
Delivery
  Eutocic 164 (53.2) 195 (52.1) 1
  Cesarean 136 (44.2) 171 (45.7) 0.9 (0.69–1.29)  0.78
  Forceps 8 (2.6) 8 (2.1) 1.2 (0.43–3.23)  0.92
Maternal pregnancy diseases
  Preeclampsia 7 (2.3) 17 (4.5) 0.5 (0.2–1.2) 0.16
  Diabetes 22 (7.1) 34 (9.1) 0.8 (0.45–1.4) 0.53
  Hypothyroidism 8 (2.6) 9 (2.4) 1.1 (0.4–2.83) 0.99
  Epilepsy or neurological disease 2 (0.6) 2 (0.5) 1.2 (0.17–8.7) 0.99
  Other diseases 16 (5.2) 22 (5.9) 0.9 (0.45–1.7) 0.82
Weight at presentation, mean (SD), kg 7.89 (3.7) 9.02 (3.5) <0.001*
Nutritional status
  Undernutrition 14 (4.5) 19 (5.1) 0.9 (0.42–1.76) 0.81
  Normal 216 (70.1) 253 (67.6) 1
  Overweight 53 (17.2) 77 (20.6) 10.8 (0.54–1.2)  0.32
  Obesity 25 (8.1) 25 (6.7) 1.2 (0.65–2.1)  0.71
Breastfeeding at 6 months of age 227 (73.7) 269 (71.9) 1.2 (0.82–1.6) 0.67
Maternal smoking during pregnancy 60 (19.5) 73 (19.5) 1.0 (0.69–1.48) 0.99
Tobacco exposure at homeb 177 (57.5) 159 (42.5) 1.8 (1.3–2.5) <0.001*
Parental history of asthma 159 (51.6) 157 (41.9) 1.5 (1.1–2.0) 0.01*
Personal history of atopy 8 (2.6) 10 (2.7) 1.0 (0.38–2.52) 0.99
Treatment for current illness
  Bronchodilators 307 (99.7) 363 (97) 9.3 (1.2–72.5) 0.015*
  Systemic corticosteroids 200 (64.9) 145 (38.7) 2.9 (2.1–4.0) <0.001*
  Antibiotics 190 (61.7) 101 (27) 4.4 (3.1–6.0) <0.001*
Viral coinfections 23 (7.5) 33 (8.8) 0.57
Positive cultures
  Blood culture 2 (0.6) 1 (0.2) 0.85
  Urine culture 11 (3.6) 10 (2.7) 0.64
Clinical bacterial coinfection 141 (45.8) 59 (15.8) 4.5 (3.2–6.5) <0.001*
Hospital length of stay, mean (SD), days 9.14 (5.16) 3.58 (1.73) <0.001*
Supplemental oxygen days, mean (SD), days 8.04 (5) 2.43 (1.59) <0.001*
PICU admission 176 (57.1) 30 (8) 15.3 (9.9–23.7) <0.001*
PICU length of stay, mean (SD), daysc 2.63 (3.79) 0.05 (0.39) <0.001*
Days of IVM, mean (SD), daysd 0.42 (2.07) 0 (0) <0.001*
Ventilatory support
  NIV 133 (43.2) 21 (5.6) <0.001*
  IMVe 25 (8.1) 0 (0)
RDAI score, mean (SD) 8.8 (3.5) 6.82 (3.5) <0.001*
TAL score, mean (SD) 5.2 (1.68) 4.1 (1.74) <0.001*
PRESS score, mean (SD) 3.65 (0.97) 2.87 (1.34) <0.001*
PIM-2 score, mean (SD)c −4.06 (0.99) −4.28 (0.68) 0.001*
Mortalityf 1 (0.3) 1 (0.26) 1

IQR interquartile range, SD standard deviation, PICU pediatric intensive care unit, NIV non-invasive mechanical ventilation, IMV invasive mechanical ventilation, RDAI Respiratory Distress Assessment Instrument, PRESS pediatric respiratory severity score, PIM-2 Pediatric Index Mortality 2

*Significant

aData represent no. (%) of patients unless otherwise specified

bAt least one parent smokes

cData for 206 patients admitted to PICU

dData for 25 patients with invasive mechanical ventilation

ep Value not calculated because one or more boxes contains zero

fIncluding 2 died infants with no respiratory reason